Skip to main content
Top
Published in: Neuroradiology 10/2015

01-10-2015 | Interventional Neuroradiology

Predictors of prognosis and treatment outcome in central retinal artery occlusion: local intra-arterial fibrinolysis vs. conservative treatment

Authors: Amelie Pielen, Stefanie Pantenburg, Claudia Schmoor, Martin Schumacher, Nicolas Feltgen, Bernd Junker, Josep Callizo, for the EAGLE Study Group

Published in: Neuroradiology | Issue 10/2015

Login to get access

Abstract

Introduction

The study analyses patients’ risk factors to determine prognostic and predictive factors in patients with acute central retinal artery occlusion (CRAO) treated in the randomized European Assessment Group for Lysis in the Eye (EAGLE) Study with local intra-arterial fibrinolysis (LIF) or conservative standard treatment (CST). These data could improve patient selection for either method.

Methods

Post hoc statistical analysis of effects of risk factors on overall best corrected visual acuity (BCVA [logarithm of the minimum angle of resolution (logMAR)]) at baseline and month 1 (prognostic effect) and on the difference between outcome of CST and LIF (predictive effect) was conducted.

Results

Seventy two of 84 EAGLE datasets were included. Prognostic effect: Patients with coronary heart disease (CHD) presented worse BCVA at baseline (0.39 logMAR, p = 0.0097). Patients with time from occlusion to treatment <12 h showed a trend to better vision gain at month 1 (−0.23 logMAR, p = 0.086), similarly smoking (−0.24 logMAR, p = 0.077). Predictive effect: Age (<60 years favours LIF −0.54 logMAR; >70 years favours CST 0.28 logMAR; interaction p = 0.070) and CHD (favours CST 0.44 logMAR; interaction p = 0.073) might be predictors of therapeutic outcome. There were no strong effects in multivariate analysis.

Conclusion

CHD, time from occlusion to treatment and smoking influence BCVA at baseline and at month 1 (prognostic effect). Patients treated within 12 h are more likely to profit from treatment. In multivariate analysis, there is no clear trend to benefit from LIF even in patients with young age, no CHD and early treatment. Based on this preliminary report on a rather small sample size, we do not recommend LIF in CRAO patients.
Literature
5.
go back to reference Schumacher M, Schmidt D, Jurklies B et al (2010) Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 117:1367–1375. doi:10.1016/j.ophtha.2010.03.061, e1 Schumacher M, Schmidt D, Jurklies B et al (2010) Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 117:1367–1375. doi:10.​1016/​j.​ophtha.​2010.​03.​061, e1
6.
go back to reference Mueller AJ, Neubauer AS, Schaller U et al (2003) Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol 121:1377–1381. doi:10.1001/archopht.121.10.1377 CrossRefPubMed Mueller AJ, Neubauer AS, Schaller U et al (2003) Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol 121:1377–1381. doi:10.​1001/​archopht.​121.​10.​1377 CrossRefPubMed
7.
go back to reference Feltgen N, Neubauer A, Jurklies B et al (2006) Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1: EAGLE Study report no. 1. Graefes Arch Clin Exp Ophthalmol 244:950–956. doi:10.1007/s00417-005-0140-2 CrossRefPubMed Feltgen N, Neubauer A, Jurklies B et al (2006) Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1: EAGLE Study report no. 1. Graefes Arch Clin Exp Ophthalmol 244:950–956. doi:10.​1007/​s00417-005-0140-2 CrossRefPubMed
8.
go back to reference Lange C, Feltgen N, Junker B et al (2009) Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol 247:137–142. doi:10.1007/s00417-008-0926-0 CrossRefPubMed Lange C, Feltgen N, Junker B et al (2009) Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol 247:137–142. doi:10.​1007/​s00417-008-0926-0 CrossRefPubMed
9.
go back to reference Luengo-Fernandez R, Paul NLM, Gray AM et al (2013) Population-based study of disability and institutionalization after transient ischemic attack and stroke 10-year results of the Oxford Vascular Study. Stroke. doi:10.1161/STROKEAHA.113.001584 PubMed Luengo-Fernandez R, Paul NLM, Gray AM et al (2013) Population-based study of disability and institutionalization after transient ischemic attack and stroke 10-year results of the Oxford Vascular Study. Stroke. doi:10.​1161/​STROKEAHA.​113.​001584 PubMed
12.
15.
go back to reference Hayreh SS, Kolder HE, Weingeist TA (1980) Central retinal artery occlusion and retinal tolerance time. Ophthalmology 87:75–78CrossRefPubMed Hayreh SS, Kolder HE, Weingeist TA (1980) Central retinal artery occlusion and retinal tolerance time. Ophthalmology 87:75–78CrossRefPubMed
16.
go back to reference Schumacher M, Schmidt D, Wakhloo AK (1993) Intra-arterial fibrinolytic therapy in central retinal artery occlusion. Neuroradiology 35:600–605CrossRefPubMed Schumacher M, Schmidt D, Wakhloo AK (1993) Intra-arterial fibrinolytic therapy in central retinal artery occlusion. Neuroradiology 35:600–605CrossRefPubMed
20.
go back to reference De Los Ríos la Rosa F, Khoury J, Kissela BM et al (2012) Eligibility for intravenous recombinant tissue-type plasminogen activator within a population: the effect of the European Cooperative Acute Stroke Study (ECASS) III Trial. Stroke 43:1591–1595. doi:10.1161/STROKEAHA.111.645986 CrossRefPubMed De Los Ríos la Rosa F, Khoury J, Kissela BM et al (2012) Eligibility for intravenous recombinant tissue-type plasminogen activator within a population: the effect of the European Cooperative Acute Stroke Study (ECASS) III Trial. Stroke 43:1591–1595. doi:10.​1161/​STROKEAHA.​111.​645986 CrossRefPubMed
Metadata
Title
Predictors of prognosis and treatment outcome in central retinal artery occlusion: local intra-arterial fibrinolysis vs. conservative treatment
Authors
Amelie Pielen
Stefanie Pantenburg
Claudia Schmoor
Martin Schumacher
Nicolas Feltgen
Bernd Junker
Josep Callizo
for the EAGLE Study Group
Publication date
01-10-2015
Publisher
Springer Berlin Heidelberg
Published in
Neuroradiology / Issue 10/2015
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-015-1588-3

Other articles of this Issue 10/2015

Neuroradiology 10/2015 Go to the issue